Sign in
Not yet recruitingNo phase

Procalcitonin Versus Serum Zinc for Diagnosis of Ventilator-Associated Pneumonia in ICU Patients

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
84 people, planned
Started
7 Jul 2026
Expected to end
Dec 2028
Type of study
Observational
Treatments tested
  • Serum Procalcitonin Measurement
  • Serum Zinc Measurement
Record updated
10 July 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • - Age 18 to 70 years
  • Adult patients admitted to the Intensive Care Unit
  • Receiving invasive mechanical ventilation for at least 48 hours
  • Clinical suspicion of ventilator-associated pneumonia (VAP)
  • New or progressive pulmonary infiltrate on chest imaging
  • At least two of the following:
  • Fever >38°C or hypothermia <36°C
  • Leukocytosis (>12,000/mm³) or leukopenia (<4,000/mm³)
  • Purulent tracheal secretions
  • Worsening oxygenation or increased ventilatory requirements
  • Written informed consent obtained from the patient or legally authorized representative

Who cannot take part

  • Known chronic liver disease
  • End-stage renal disease requiring dialysis
  • Immunocompromised patients (including HIV infection, chemotherapy, organ transplantation, or long-term immunosuppressive therapy)
  • Current zinc supplementation or known disorders of zinc metabolism
  • Hematologic malignancies
  • Autoimmune diseases requiring immunosuppressive treatment
  • Active non-pulmonary bacterial infection requiring systemic antibiotic therapy
  • Chronic inflammatory diseases that may affect serum zinc levels
  • - Age less than 18 years or greater than 70 years
  • Pregnancy
  • Refusal or inability to provide informed consent

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Ventilator-associated pneumonia (VAP) is a common and serious infection among mechanically ventilated ICU patients. Early diagnosis remains challenging because clinical and radiological findings may lack specificity. Procalcitonin (PCT) is a well-established biomarker of bacterial infection, while serum zinc has recently emerged as a potential marker of immune dysfunction and infection severity. This prospective observational cohort study will compare the diagnostic accuracy of serum procalcitonin and serum zinc for the diagnosis of ventilator-associated pneumonia in 84 adult ICU patients. Diagnostic performance will be assessed using ROC curve analysis, sensitivity, specificity, positive predictive value, and negative predictive value. Associations between biomarker levels, inflammatory markers, disease severity scores, and clinical outcomes will also be evaluated.

The group in the trial

  • Suspected VAP Patients

    Adult mechanically ventilated ICU patients with suspected ventilator-associated pneumonia enrolled for diagnostic evaluation using serum procalcitonin and serum zinc measurements. Participants will subsequently be classified according to the final diagnosis of VAP based on clinical, radiological, and microbiological criteria.

    Treatment: Serum Procalcitonin Measurement and Serum Zinc Measurement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Diagnostic Accuracy of Procalcitonin Versus Serum Zinc as Biomarkers for the Diagnosis of Ventilator Acquired Pneumonia in Adults Admitted to the ICU
Criteria questions
Built from NCT07696897, who can take part
Record updated
10 July 2026